Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about NVS

Recent news which mentions NVS

< Previous 1 2 3 4 5 6 7 8 9
...
26 27 Next >
Sanofi To Navigate Tariff Impact With $20 Billion In Spending Through 2030
Tickers BDX BMY JNJ LLY
Tags Health Care BDX SNY
From Benzinga
Protagonist/Johnson & Johnson Partnered Drug Shows Significant Skin Clearance In Pivotal Psoriasis Study
Tickers JNJ NEWS NVS PTGX
Tags Market News UCBJF PTGX
From Benzinga
FDA Expands Surprise Inspections At Foreign Drug And Food Facilities, Targets Double Standards In Overseas Manufacturing Oversight
Tickers BDX BMY JNJ LLY
Tags BDX tariffs REGN
From Benzinga
BioNTech Appoints Novartis Executive As Finance Chief, Reaffirms 2025 Outlook Focusing on Oncology Expansion
Tickers BNTX NEWS NVS PFE
Tags Guidance Briefs NVS
From Benzinga
Humana Does Not Alter 2025 Outlook Despite Sales Miss And Medicare Membership Decline
Tickers HUM NEWS NVS
Tags News Large Cap Health Care
From Benzinga
Novartis To Buy US Kidney Drug Developer Regulus Therapeutics For Around $800 Million
Tickers NEWS NVS RGLS
Tags Benzinga why it's moving General
From Benzinga
Novartis Q1 Earnings Beat Street View, CEO 'Confident' In Delivering Upgraded Guidance
Tickers NEWS NVS
Tags News Large Cap Health Care
From Benzinga
US Stock Futures Edge Higher Tuesday: Expert Warns Of 'Perfect Volatility Storm' With Major Earnings And Economic Data Due This Week
Tickers AAPL ABBV AMZN AON
Tags NASDAQ Benzinga Russell 2000
From Benzinga
General Motors, Coca-Cola And 3 Stocks To Watch Heading Into Tuesday
Tickers GM KO NEWS NVS
Tags SBUX NVS Markets
From Benzinga
Earnings Scheduled For April 29, 2025
Tickers AAT ABG ACGL AEYE
Tags PUMP QUAD NVS
From Benzinga
Earnings Preview For Novartis
Tickers NVS
Tags Earnings Market News BZI/EP
From Benzinga
These 2 Top Dividend Stocks Are Making Moves to Avoid the Impact of Tariffs: Are They Buys?
Tickers JNJ NVS
Tags Market News JNJ Recent Press Releases
From Motley Fool
Roche Plans $50 Billion US Investment Over 5 Years With 12,000 New Jobs
Tickers JNJ LLY NEWS NVS
Tags LLY Health Care Large Cap
From Benzinga
S&P 500, Nasdaq Futures Rise After Stocks Dip Amid Trump's Jabs At Powell, Strong Yen Gives Nikkei A Volatile Start
Tickers LMT NVS SAP TSLA
Tags NVS VZ Market News
From Benzinga
2 Dividend Stocks Defying the Tariff-Fueled Market Correction to Buy and Hold Forever
Tickers AMGN AZN NVS
Tags AMGN Recent Press Releases NVS
From Motley Fool
Novartis Commits $23 Billion To Expand US Manufacturing Over Five Years, Despite Tariffs Uncertainties
Tickers JNJ LLY NEWS NVS
Tags Stories That Matter Biotech Benzinga
From Benzinga
Pharma Industry Faces Jitters As Trump Hints At Historic Tariffs, BofA Outlines Probable Timeline
Tickers ARGX AZN GILD GSK
Tags NVS Briefs Movers
From Benzinga
Cell Therapy Maker Legend Biotech Is An 'Attractive Opportunity' Due To No Material Tariff Exposure: Analyst
Tickers JNJ LEGN NEWS NVS
Tags Market News Briefs NVS
From Benzinga
3 Health Care Stocks Whale Activity In Today's Session
Tickers CVS NVS TLRY
Tags Benzinga BZI/AUOA Options
From Benzinga
Novartis Secures Third FDA Approval For Its Kidney Disease Portfolio In One Year
Tickers NEWS NVS
Tags News Health Care Movers
From Benzinga
FDA Reviews Kidney Disease Drug From Apellis Pharmaceuticals
Tickers APLS NEWS NVS
Tags Briefs NVS Movers
From Benzinga
FDA OKs Novartis Prostate Cancer Treatment, Triples Eligible Patient Pool
Tickers NEWS NVS
Tags NVS Briefs Market News
From Benzinga
Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed
Tickers AMGN AZN BIIB BMY
Tags Stories That Matter RHHBY General
From Benzinga
FDA Approves Expanded Use Of Novartis Rare Disease Drug As Only Treatment For Rare Type Of Kidney Disease
Tickers NEWS NVS
Tags Market News Briefs NVS
From Benzinga
Novartis Partner Monte Rosa Therapeutics Touts Positive Data From Early-Stage Study Of Investigational Drug Candidate For Immune-Mediated Disorders
Tickers GLUE NEWS NVS
Tags News General Benzinga
From Benzinga
Novartis New Data From Single-Dose Gene Therapy Shows Meaningful Efficacy, Safety In Patients With Spinal Muscular Atrophy
Tickers BIIB NEWS NVS RHHBY
Tags Biotech RHHBY Stories That Matter
From Benzinga
The Best Vanguard ETF to Invest $1,000 in Right Now
Tickers NSRGY NVS RHHBY SAP
Tags NVS Recent Press Releases RHHBY
From Motley Fool
These 2 Vanguard ETFs Are Crushing the S&P 500 in 2025. Should You Buy?
Tickers CBA HSBC HTHIY MUFG
Tags RHHB/F ^GSPC CBA
From Motley Fool
Teladoc Health Partners With Eli Liily's LillyDirect to Expand Access to Zepbound For Weight Loss
Tickers LLY NEWS NVS TDOC
Tags Stories That Matter Weight Loss Benzinga
From Benzinga
Roche Touts Food Allergy Drug As Superior Than Oral Immunotherapy
Tickers NEWS NVS RHHBY
Tags Top Stories Benzinga General
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
26 27 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.